Uruguayan Government Grants Plandai Biotechnology Provisional License for the Research & Development of Prescription Cannabinoid Medicines

LOGAN, UT--(Marketwired - May 14, 2015) -Plandaí Biotechnology, Inc. (PLPL) (“Plandaí” or “the Company”), announced today that the Government of Uruguay, through its Institute of Regulation and Control of Cannabis (IRCCA), granted Plandai Biotechnology Uruguay S.A. a provisional license under the Marijuana and Derivates Law 19.172, Decree No.46/2015, Articles 6 and 9, to establish a scientific program for the research, and development of prescription cannabinoid medicines.

 

The Company’s legal counsel, Ferrere Abogados of Montevideo, Uruguay, represented the Company throughout the licensing process. The Company’s license is provisional and subject to the Company submitting additional information to the IRCCA within 90 days in order to finalize issuance of the license. The Company, in conjunction with its counsel, expects to submit all required paperwork to the IRCCA in a timely fashion and will update shareholders on its progress.

Once issued, the Company’s license will allow...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://finance.yahoo.com/news/uruguayan-government-grants-plandai-biotechnology-130000545.html